
### [NCIT:C8845](http://purl.obolibrary.org/obo/NCIT_C8845)
**Label:** Stage IV B-Cell Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C8867](http://purl.obolibrary.org/obo/NCIT_C8867) (Stage IV Nodal Marginal Zone Lymphoma), [NCIT:C8879](http://purl.obolibrary.org/obo/NCIT_C8879) (Stage IV Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8857](http://purl.obolibrary.org/obo/NCIT_C8857) (Stage IV Diffuse Large B-Cell Lymphoma), [NCIT:C5006](http://purl.obolibrary.org/obo/NCIT_C5006) (Stage IV Follicular Lymphoma), [NCIT:C8656](http://purl.obolibrary.org/obo/NCIT_C8656) (Stage IV Lymphoplasmacytic Lymphoma), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C5088](http://purl.obolibrary.org/obo/NCIT_C5088) (Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8873](http://purl.obolibrary.org/obo/NCIT_C8873) (Stage IV B Lymphoblastic Lymphoma), [NCIT:C5084](http://purl.obolibrary.org/obo/NCIT_C5084) (Stage IV Burkitt Lymphoma), [NCIT:C8486](http://purl.obolibrary.org/obo/NCIT_C8486) (Stage IV Mantle Cell Lymphoma), [NCIT:C8145](http://purl.obolibrary.org/obo/NCIT_C8145) (Stage IV Grade 3 Follicular Lymphoma), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C8152](http://purl.obolibrary.org/obo/NCIT_C8152) (Stage IV Adult Burkitt Lymphoma), [NCIT:C8141](http://purl.obolibrary.org/obo/NCIT_C8141) (Stage IV Small Lymphocytic Lymphoma), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C68683](http://purl.obolibrary.org/obo/NCIT_C68683) (Stage IV Marginal Zone Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 53.57%
- Thing 53.00%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.93%


